Momentact Analgesico (Ibuprofen Sodium Dihydrate)

Ibuprofen inhibits the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are essential for producing prostaglandins. By lowering prostaglandin levels, it reduces inflammation, lowers elevated body temperature, and diminishes the sensitization of nerve endings that convey pain signals.

The appropriate dose of Momentact Analgesico is determined by the prescribing clinician based on the patient’s age, weight, medical condition, and response to therapy. Patients should follow the exact dosing instructions provided by their healthcare professional and never adjust the dose on their own.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. It is generally avoided in the third trimester and used only if clearly needed earlier in pregnancy. Breastfeeding mothers should consult their physician, as ibuprofen does pass into breast milk in small amounts.

To place an order, submit an enquiry on the Momentact Analgesico product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Momentact Analgesico (ibuprofen) shares the core anti‑inflammatory and analgesic properties of the NSAID class but differs in its pharmacokinetic profile, dosing frequency, and gastrointestinal safety profile compared with agents like naproxen or diclofenac. Choice of NSAID often depends on individual patient tolerance, comorbidities, and physician preference.

Store Momentact Analgesico at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight, and excessive heat to maintain stability and potency throughout its shelf life.

Momentact Analgesico is taken orally, usually with a full glass of water. It may be taken with food or milk to lessen gastrointestinal irritation, but patients should follow the specific instructions given by their prescriber regarding timing and whether it should be taken with meals.

Serious risks include gastrointestinal bleeding or ulcer perforation, acute kidney injury, severe allergic reactions such as anaphylaxis, and rare cardiovascular events like myocardial infarction or stroke, especially with high‑dose or prolonged use. Patients should seek immediate medical attention if they experience signs of these conditions.

Individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding, severe renal or hepatic impairment, and patients in the third trimester of pregnancy should avoid using Momentact Analgesico unless directed otherwise by a healthcare professional.